Both of these put energy underneath your skin. They get there by completely different routes. Endolift threads a thin laser fibre under the skin through a needle entry point and heats outwards from there. Morpheus8 pushes insulated needles down through the skin from the outside and releases radiofrequency current at their tips.
One is a small procedure done under local anaesthetic. The other is a treatment stamped on the skin surface. With Endolift a fibre is passed along the plane just beneath the skin. With Morpheus8 an array of needles is pressed into the skin and fired, over and over, across the treatment area.
Neither is cleared in the US for lifting or tightening. The laser used for Endolift, the Eufoton LASEmaR 1500, does hold a US clearance, K260489, granted 29 May 2026. But it is a surgical laser clearance: vaporisation, incision, excision, ablation and cutting, plus hemostasis or coagulation used with endoscopy equipment, and laser-assisted lipolysis, which means breaking down fat. Lifting, tightening and skin laxity appear nowhere in it, and no device is cleared under the name "Endolift" at all. Morpheus8's clearances name no cosmetic use either.
The published evidence is thin on both sides, in different ways. No clinical trial of Endolift was found in the published literature. Morpheus8 has published studies attached to its name, but very few: a PubMed search returns 16 records and no randomised controlled trial. Most of the research people are shown when they search "Morpheus8" was generated on other machines entirely.
Done under local anaesthetic. It is predominantly performed outside the United States.
An array of needles, coated except at the very tip, energised once they are in the skin.
Energy is deposited in a short distance around the fibre tip. That produces local heating, a small amount of fat reduction, and thermal contraction of the fibrous strands and the underside of the skin.
The heating is electrical rather than light-based, so it does not depend on skin pigment in the way a laser does. The pins are coated with insulation except the last 0.5 mm, which keeps heat off the surface layer.
That is the defining feature: the energy source is inside the tissue, not on top of it.
Manufacturer labelling lists a fixed 0.5 mm resurfacing tip, 1 to 4 mm on the 12-pin tip, 1 to 7 mm on the 24-pin tip and 2 to 7 mm on the 40-pin body tip. The deepest figure in any FDA summary is 7.0 mm.
The 2026 clearance (K260489) covers vaporisation, incision, excision, ablation and cutting, plus hemostasis or coagulation used with endoscopy equipment, and laser-assisted lipolysis, across several specialties including aesthetic medicine. It says nothing about lifting, tightening or skin laxity.
That is K192695, December 2019. A 2023 clearance, K231790, added "coagulation/contraction of soft tissue". No Morpheus8 clearance names acne scars, wrinkles, laxity, cellulite or fat.
Outside the US it is used along the jawline and under the chin, on jowls and nasolabial laxity, around the eyes and brow, and on arms, knees and abdomen. That is what it is used for rather than what has been measured, because no published trial of it was found.
Across the radiofrequency microneedling class, acne scarring is the best-evidenced use: a systematic review covering 16 studies and 481 patients, 6 of them randomised trials. In a same-patient split-face trial, radiofrequency microneedling matched fractional CO2 laser on acne scar scores, with shorter redness and fewer patches of darkened skin afterwards.
Clinics describe several days up to about two weeks. No study and no US labelling establishes that, so treat it as the conventional description rather than a measured figure.
In a 44-person acne scar study, redness occurred in 100 per cent of patients and swelling in 30 per cent. A 33-person neck study put downtime at 3 to 4 days. Skin barrier measurements rise for the first three days and are back to baseline by day 7.
Ask the person offering it how many they plan and on what basis.
It adds that 3 to 5 sessions are generally needed at mild to moderate depth settings. Published trials most often used 3.
This is the sharpest practical difference between them.
Fat reduction is part of what Endolift is designed to do. Its wavelength is absorbed by water and to a degree by fat, and laser-assisted lipolysis is named in the laser's own cleared wording. Small-volume fat reduction is the point, not a side effect.
On the Morpheus8 side, fat loss appears as an unwanted event. An analysis of the FDA's post-market reporting database covering January 2013 to October 2025 found 114 reports containing 224 events, of which 26 were fat loss - the third most reported category. That database is voluntary and has no denominator, so it is a proportion of reports and can never be read as a chance of something happening to you.
And the one study that measured it found no change. A split-face study in 30 people who completed it measured the area under the chin by ultrasound after microneedle fractional radiofrequency. The dermis thickened. The fat layer did not change significantly. The paper's own title contains the phrase "without Lipolysis".
So: intended on one side, an occasionally reported complication on the other, and not something Morpheus8 is cleared or shown to do.
Six months is where the measured evidence stops for radiofrequency microneedling. A critical review of 42 higher-quality studies concluded that the collagen remodelling is slow and progressive and continues to improve even 6 months after treatment. That is a statement about improvement up to 6 months, not about durability beyond it. Clinic copy saying results last 1 to 3 years has no published source.
For Endolift there is no measured durability at all, because there is no published trial.
Radiofrequency heating does not depend on pigment the way light does, which is why radiofrequency microneedling is used across a wide range of skin tones and produced fewer patches of darkened skin than fractional CO2 laser in a same-patient trial.
There is a limit written into the paperwork, though. Morpheus8's clearance restricts energies above 62 mJ per pin to Fitzpatrick skin types I to IV. Above that setting, deeper skin tones are outside the cleared labelling. Ask what energy per pin is planned and ask for a test area.
For Endolift, no published data on pigmentary outcomes was found either way.
If you get cold sores, say so when you book - not on the day. Antiviral medicine is started in advance, so it has to be prescribed beforehand. There is no published data on cold-sore reactivation after radiofrequency microneedling specifically; the precaution is carried over from laser resurfacing, where reactivation is well documented and prophylaxis is standard.
Tell your provider about a pacemaker or an implantable defibrillator, and about any metal implant near the treatment area, before any radiofrequency treatment. These are labelled contraindications for radiofrequency devices and they are precautionary rather than tested - the right people to advise you are your cardiology team, not a clinic.
For Endolift, ask who is performing it, what anaesthetic is used, and what their plan is if the result is uneven.
These can mean a spreading infection and need urgent care the same day.